Stock Screener App

無料 - Play StoreApp Store

インストールインストール

XENE

$38.522.39%0.90

Xenon Pharmaceuticals Inc (XENE)

Date: O: H: L: C: Vol:

Xenon Pharmaceuticals Inc (XENE) 最新ニュース

Precision Trading with Xenon Pharmaceuticals Inc. (XENE) Risk Zones - Stock Traders Daily

Form 4 Xenon Pharmaceuticals Inc.: Ian Mortimer (Director, PRESIDENT & CEO) For: 30 September By Investing.com - Investing.com South Africa

Form 4 Xenon Pharmaceuticals Inc.: Ian Mortimer (Director, PRESIDENT & CEO) For: 30 September - Investing.com UK

Form 4 Xenon Pharmaceuticals Inc.: Thomas Patrick Kelly (CFO) For: 30 September - Investing.com UK

Xenon Pharmaceuticals Inc. Estimates – NASDAQ:XENE - TradingView

Xenon Pharmaceuticals Inc. (XENE) Options Chain - Yahoo Finance - Yahoo! Finance Canada

Xenon Pharmaceuticals Inc. (XENE) stock price, news, quote and history - Yahoo Finance Singapore

Wolf Popper LLP Continues Investigation on Behalf of Xenon Pharmaceuticals Inc. Investors - GlobeNewswire Inc.

Wolf Popper LLP Continues Investigation on Behalf of Xenon Pharmaceuticals Inc. Investors - GlobeNewswire

Wells Fargo sets USD 64 target for Xenon Pharmaceuticals stock - ad-hoc-news.de

A Quick Look at Today's Ratings for Xenon Pharmaceuticals(XENE.US), With a Forecast Between $60 to $90 - Moomoo

Form 4 Xenon Pharmaceuticals Inc.: Thomas Patrick Kelly (CFO) For: 15 October - Investing.com Nigeria

Xenon Pharmaceuticals CFO Kelly Thomas Patrick Converts 7,500 RSUs into Common Shares - Kalkine Media

Vesting adds 7,500 shares for Xenon Pharmaceuticals (XENE) CFO; direct holdings total 22,500. - Stock Titan

Xenon Pharmaceuticals Inc. (XENE) stock price, news, quote and history - Yahoo Finance UK

XENE's Depression Trial Setback: Is Its Pipeline Still Attractive? - Zacks Investment Research

XENE's Depression Trial Setback: Is Its Pipeline Still Attractive? - TradingView

Xenon grants 28,350 awards as Xenon Pharmaceuticals stock is valued at USD 3.3 billion - ad-hoc-news.de

Technical Reactions to XENE Trends in Macro Strategies - Stock Traders Daily

Xenon Pharmaceuticals stock hits 52-week low at 35.04 USD - Investing.com

Full Transcript: Xenon Pharmaceuticals Q2 2026 Earnings Call - Benzinga

XENE Investors Have Opportunity to Join Xenon Pharmaceuticals Inc. Fraud Investigation with SBS Law - The National Law Review

Xenon Pharmaceuticals Inc Stock Warning Signs | MEX:XENE N - GuruFocus

Xenon Pharmaceuticals Inc Stock Intrinsic Values - GuruFocus

Why Xenon Pharmaceuticals (XENE) Is Getting Attention Now - Yahoo Finance

Xenon Pharmaceuticals (XENE) Stock May Still Look Above Fair Value On Its Research Pipeline - Yahoo Finance

Wolf Popper LLP Continues Investigation on Behalf of Xenon Pharmaceuticals Inc. Investors - GlobeNewswire

Wolf Popper LLP Continues Investigation on Behalf of Xenon Pharmaceuticals Inc. Investors - GlobeNewswire

Xenon Pharmaceuticals stock hits 52-week low at 36.06 USD - Investing.com

Xenon Pharmaceuticals stock hits 52-week low at 36.06 USD By Investing.com - Investing.com Canada

XENE Assumed by Guggenheim -- Buy Rating Assigned with Price Tar - GuruFocus

Xenon Pharmaceuticals stock gets 28,350 awards for new hires - AD HOC NEWS

President of Xenon Pharmaceuticals Picks Up 88% More Stock - Simply Wall Street

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Eight new Xenon employees get options to buy shares at $38.93 - Stock Titan

Xenon Pharmaceuticals (XENE) Shares Rise After CEO and CFO Buy $1.7M in Stock - GuruFocus

Xenon rises on insider buys from CEO and CFO (XENE:NASDAQ) - Seeking Alpha

Xenon Pharmaceuticals (XENE) CFO Thomas Kelly Buys 15,000 Shares in Open-Market Purchase - GuruFocus

Xenon's AZK Approval Path Unlikely to Be Hurt by Safety Issues, RBC Says - Yahoo Finance

Xenon Pharmaceuticals Insider Bought Shares Worth $1,121,400, According to a Recent SEC Filing - Yahoo Finance

At $37.316 each, CFO Kelly buys 15,000 Xenon Pharmaceuticals (XENE) shares. - Stock Titan

At $37.38 a share, Xenon Pharmaceuticals (XENE) CEO Ian Mortimer buys company stock. - Stock Titan

Gross margin % of Xenon Pharmaceuticals Inc. – HAN:XP0 - TradingView

Xenon Pharmaceuticals stock trades at EUR 32.70 after FDA filing - AD HOC NEWS

Total common shares outstanding of Xenon Pharmaceuticals Inc. – HAN:XP0 - TradingView

Xenon Pharmaceuticals Inc. Balance Sheet – HAN:XP0 - TradingView

Xenon Pharmaceuticals stock trades at EUR 32.30 after trial pause - AD HOC NEWS

Xenon Pharmaceuticals Inc. (XENE) Interactive Stock Chart - Yahoo Finance - Yahoo! Finance Canada

Xenon Pharmaceuticals Inc. (XENE) Stock Price, News, Quote & History - Yahoo! Finance Canada

Xenon Pharmaceuticals Inc. (XENE) stock price, news, quote and history - Yahoo Finance Australia

XENEに類似

PBLS$29.317.56%

IRON$81.133.19%

RLAY$17.611.91%

ACAD$20.630.78%

ABCL$12.128.95%